Contact your healthcare provider if diarrhea persists beyond 2-4 weeks at a stable dose, if you experience severe or bloody diarrhea, signs of dehydration (dizziness, decreased urination, extreme thirst), severe abdominal pain, or if symptoms significantly interfere with daily activities or medication adherence
Population PK analyses including data from this single-dose study and predicting PK parameters after repeated subcutaneous administration of Lanadelumab 300 mg every two weeks showed that geometric mean ratios (90% CIs) were 1.001 (0.9481.056) for AUC over the dosing interval at steady state and 1.029 (0.9811.081) for C max at steady state
for details, see Additional File 1
However, the disease does not usually create a solid tumor, and its considered a type of non-Hodgkin lymphoma
however, they require prior authorization (PA)
Stopped-flow kinetic measurements For all stopped-flow measurements, freshly purified proteins were reduced with 5 mM DTT on ice for 30 min